Pharma spending commitments to the country amount to 1.4 billion pounds since the first U.K.-U.S. pharma deal was announced in December, according to a tally by the Association of the British Pharmaceutical Industry, a trade group. "AstraZeneca Plans U.K. Investment as Cancer Drugs Lift Revenue -- Update," at 1511 GMT, incorrectly said spending commitments amounted to 1.575 billion pounds.


(END) Dow Jones Newswires

04-29-26 1228ET